Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding
- PMID: 11336709
- DOI: 10.1016/s1097-2765(01)00230-1
Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding
Abstract
The neonatal Fc receptor (FcRn) transports immunoglobulin G (IgG) across epithelia, binding IgG in acidic vesicles (pH < or = 6.5) and releasing IgG in the blood at pH 7.4. Well-ordered FcRn/Fc crystals are prevented by the formation of "oligomeric ribbons" of FcRn dimers bridged by Fc homodimers, thus we crystallized a 1:1 complex between rat FcRn and a heterodimeric Fc containing only one FcRn binding site. The 2.8 A complex structure demonstrates that FcRn uses its alpha2 and beta2-microglobulin domains and carbohydrate to interact with the Fc C(gamma)2-C(gamma)3 interface. The structure reveals conformational changes in Fc and three titratable salt bridges that confer pH-dependent binding, and can be used to guide rational design of therapeutic IgGs with longer serum half-lives.
Similar articles
-
Characterization of the 2:1 complex between the class I MHC-related Fc receptor and its Fc ligand in solution.Biochemistry. 1999 Sep 28;38(39):12639-47. doi: 10.1021/bi9913505. Biochemistry. 1999. PMID: 10504233
-
Stoichiometry of the interaction between the major histocompatibility complex-related Fc receptor and its Fc ligand.Biochemistry. 1999 Jul 20;38(29):9471-6. doi: 10.1021/bi9907330. Biochemistry. 1999. PMID: 10413524
-
Qualification of a homogeneous cell-based neonatal Fc receptor (FcRn) binding assay and its application to studies on Fc functionality of IgG-based therapeutics.J Immunol Methods. 2013 Apr 30;390(1-2):81-91. doi: 10.1016/j.jim.2013.01.011. Epub 2013 Feb 4. J Immunol Methods. 2013. PMID: 23384837
-
Neonatal Fc receptor (FcRn): a novel target for therapeutic antibodies and antibody engineering.J Drug Target. 2014 May;22(4):269-78. doi: 10.3109/1061186X.2013.875030. Epub 2014 Jan 9. J Drug Target. 2014. PMID: 24404896 Review.
-
FcRn: from molecular interactions to regulation of IgG pharmacokinetics and functions.Curr Top Microbiol Immunol. 2014;382:249-72. doi: 10.1007/978-3-319-07911-0_12. Curr Top Microbiol Immunol. 2014. PMID: 25116104 Review.
Cited by
-
Soluble monomeric IgG1 Fc.J Biol Chem. 2012 Jun 1;287(23):19399-408. doi: 10.1074/jbc.M112.368647. Epub 2012 Apr 19. J Biol Chem. 2012. PMID: 22518843 Free PMC article.
-
Oral delivery of anti-MDM2 inhibitor SP141-loaded FcRn-targeted nanoparticles to treat breast cancer and metastasis.J Control Release. 2016 Sep 10;237:101-14. doi: 10.1016/j.jconrel.2016.07.008. Epub 2016 Jul 6. J Control Release. 2016. PMID: 27394681 Free PMC article.
-
Evolutionary trajectory of receptor binding specificity and promiscuity of the spike protein of SARS-CoV-2.Protein Sci. 2022 Nov;31(11):e4447. doi: 10.1002/pro.4447. Protein Sci. 2022. PMID: 36305765 Free PMC article.
-
The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding.Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10641-6. doi: 10.1073/pnas.162360499. Epub 2002 Jul 16. Proc Natl Acad Sci U S A. 2002. PMID: 12122212 Free PMC article.
-
X-ray crystal structures of monomeric and dimeric peptide inhibitors in complex with the human neonatal Fc receptor, FcRn.J Biol Chem. 2010 Sep 3;285(36):27694-701. doi: 10.1074/jbc.M110.120667. Epub 2010 Jun 30. J Biol Chem. 2010. PMID: 20592032 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources